ISCA, CHRYSTEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.194
EU - Europa 1.987
AS - Asia 1.840
SA - Sud America 318
AF - Africa 69
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.427
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.105
IT - Italia 716
SG - Singapore 483
CN - Cina 431
IE - Irlanda 254
GB - Regno Unito 240
BR - Brasile 221
VN - Vietnam 201
HK - Hong Kong 194
DE - Germania 173
SE - Svezia 153
BD - Bangladesh 140
FR - Francia 84
RU - Federazione Russa 76
IN - India 75
FI - Finlandia 71
KR - Corea 52
CA - Canada 48
ID - Indonesia 45
AR - Argentina 34
TR - Turchia 34
JP - Giappone 29
IQ - Iraq 27
EG - Egitto 26
LT - Lituania 26
NL - Olanda 26
MX - Messico 23
TW - Taiwan 23
UA - Ucraina 22
BG - Bulgaria 21
CO - Colombia 20
BE - Belgio 18
ES - Italia 18
MY - Malesia 18
PL - Polonia 18
PK - Pakistan 17
AU - Australia 15
CL - Cile 14
CZ - Repubblica Ceca 14
EC - Ecuador 12
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 10
AT - Austria 9
SA - Arabia Saudita 9
MD - Moldavia 8
MA - Marocco 7
VE - Venezuela 7
JO - Giordania 6
KE - Kenya 6
SY - Repubblica araba siriana 6
NP - Nepal 5
BH - Bahrain 4
DZ - Algeria 4
EU - Europa 4
GR - Grecia 4
HR - Croazia 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
CR - Costa Rica 2
GA - Gabon 2
GH - Ghana 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
KH - Cambogia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
GT - Guatemala 1
HT - Haiti 1
IL - Israele 1
Totale 7.422
Salva come PNG Salva come JPEG
Città #
Ashburn 440
Santa Clara 321
Singapore 276
Chandler 255
Dublin 251
Hong Kong 186
San Jose 186
Fairfield 179
Dallas 136
Beijing 105
Nyköping 99
Hefei 98
New York 86
Council Bluffs 79
Houston 78
Southend 77
London 71
Los Angeles 71
Woodbridge 67
Helsinki 64
Ann Arbor 63
Milan 59
Seattle 59
Ho Chi Minh City 58
Modena 56
Wilmington 49
Cambridge 48
Seoul 47
Bologna 45
The Dalles 45
Hanoi 40
Dearborn 39
Chicago 34
Jakarta 31
Munich 31
Rome 31
Fremont 29
Lauterbourg 28
Frankfurt am Main 26
Redwood City 26
Shanghai 26
Moscow 23
San Diego 23
Orem 22
Tokyo 22
Sofia 21
São Paulo 21
Princeton 20
Baghdad 19
Toronto 19
Asyut 18
Buffalo 18
Bremen 16
Parma 16
Portsmouth 16
San Giuliano Milanese 15
Banqiao 14
Jacksonville 14
Mumbai 14
Reggio Emilia 14
Columbus 13
Des Moines 13
Warsaw 13
Brooklyn 12
Brussels 12
Da Nang 12
Dong Ket 12
Haiphong 12
Lawrence 12
Eugene 11
Madrid 11
Nuremberg 11
Phoenix 11
Poplar 11
Sassuolo 11
Denver 10
Izmir 10
Mexico City 10
Belo Horizonte 9
Brno 9
Castelvetrano 9
Düsseldorf 9
Guangzhou 9
Paris 9
Absecon 8
Atlanta 8
Cardiff 8
Chennai 8
Chisinau 8
Manchester 8
Redondo Beach 8
Schiffdorf 8
Amsterdam 7
Bari 7
Melbourne 7
Montreal 7
Porto Alegre 7
Quito 7
Santorso 7
Boardman 6
Totale 4.720
Salva come PNG Salva come JPEG
Nome #
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. 621
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? 453
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 397
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 361
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 353
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis 346
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 343
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 316
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 288
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 286
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 284
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 279
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 259
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 256
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 256
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 256
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 253
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 249
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 249
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. 230
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 228
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 211
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affectclinical outcome of metastatic breast cancer patients 191
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: A single institutional retrospective report 190
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 165
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 160
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer 10
Totale 7.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202171 0 0 0 0 0 0 0 0 0 0 0 71
2021/2022526 57 41 33 28 20 46 20 24 47 53 95 62
2022/2023978 79 121 58 82 80 79 16 70 300 29 32 32
2023/2024605 28 25 51 65 59 75 76 57 33 30 53 53
2024/20251.493 45 18 36 104 273 202 129 111 166 103 118 188
2025/20262.872 198 79 270 256 376 163 358 149 241 284 237 261
Totale 7.490